CAS: 263251-78-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Tavilermide REF: AN-AG00BJXGCAS: 263251-78-1 | ≥98% | To inquire | Wed 15 May 24 |
 | Tavilermide REF: 3D-NKA25178CAS: 263251-78-1 | Min. 98 Area-% | 298.00 €~1,912.00 € | Wed 26 Jun 24 |
 | Tavilermide REF: TM-T17000CAS: 263251-78-1 | 98% | 143.00 €~2,367.00 € | Wed 03 Jul 24 |
Ref: AN-AG00BJXG
| 1mg | 326.00 € | |
| 5mg | To inquire | |
| 10mg | To inquire |
Estimated delivery in United States, on Wednesday 15 May 2024
Tavilermide
CAS:263251-78-1
Tavilermide is a conjunctival diagnostic agent that is used to identify inflammatory diseases. It is …
Formula:
C24H32N6O11
Purity:
Min. 98 Area-%
Molecular weight:
580.54 g/mol
Ref: 3D-NKA25178
| 1mg | 298.00 € | |
| 2mg | 462.00 € | |
| 5mg | 711.00 € | |
| 10mg | 1,016.00 € | |
| 25mg | 1,912.00 € |
Estimated delivery in United States, on Wednesday 26 Jun 2024
Tavilermide
CAS:263251-78-1
Tavilermide is a selective and partial agonist of TrkA or a nerve growth factor mimetic.
Formula:
C24H32N6O11
Purity:
98%
Color and Shape:
Solid
Molecular weight:
580.54
Ref: TM-T17000
| 5mg | 419.00 € | |
| 25mg | 1,410.00 € | |
| 50mg | 1,865.00 € | |
| 100mg | 2,367.00 € |
Estimated delivery in United States, on Wednesday 3 Jul 2024
